Profile
John A. Scarlett was the founder of Sensus Drug Development Corp.
as President & Chief Executive Officer since 1993.
Dr. Scarlett was the founder of Tercica, Inc. as Chief Executive Officer & Director since 2002.
Dr. Scarlett was the founder of Covance Biotechnology Services, Inc. as Director since 1995.
Dr. Scarlett is also the founder of Labcorp Drug Development, Inc. Dr. Scarlett served as President & Chief Executive Officer at Proteolix, Inc. in 2009.
Dr. Scarlett served as Chairman, President & Chief Executive Officer at Geron Corp.
from 2018 to 2025.
Dr. Scarlett served as Independent Director at Chiasma, Inc. from 2015 to 2021.
Dr. Scarlett served as Director-Medical Research & Services at Ortho-McNeil Pharmaceutical LLC from 1982 to 1985.
Dr. Scarlett served as Independent Director at CytomX Therapeutics, Inc. from 2016 to 2022.
Dr. Scarlett served as Vice President-Clinical Affairs at Greenwich Pharmaceuticals, Inc. from 1985 to 1990.
Dr. Scarlett served as Senior Vice President-Medical & Scientific Affairs at Novo Nordisk Pharmaceutical Industries, Inc. from 1991 to 1993.
Education includes an undergraduate degree from Earlham College and a doctorate from Pritzker School of Medicine.
Former positions of John Scarlett
| Companies | Position | End |
|---|---|---|
| GERON CORPORATION | Chief Executive Officer | 10/03/2025 |
| CYTOMX THERAPEUTICS, INC. | Director/Board Member | 14/06/2022 |
| CHIASMA, INC. | Director/Board Member | 04/08/2021 |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Chief Executive Officer | 31/10/2009 |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Founder | 16/10/2008 |
Training of John Scarlett
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Labcorp Drug Development, Inc.
Labcorp Drug Development, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory testing and drug development services | Health Services |
Sensus Drug Development Corp.
Sensus Drug Development Corp. Pharmaceuticals: OtherHealth Technology Develops drugs to treat endocrine disorders | Health Technology |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Health Technology |
Chiasma, Inc.
Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
Ortho-McNeil Pharmaceutical LLC
Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Greenwich Pharmaceuticals, Inc.
Greenwich Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Commercial physical research | Commercial Services |
Covance Biotechnology Services, Inc.
Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Earlham College
Earlham College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Health Technology |
Novo Nordisk Pharmaceutical Industries, Inc.
Novo Nordisk Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
Pritzker School of Medicine
Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- John Scarlett
















